Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Brochure
September 28, 2016

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy
The use of biomarkers in clinical drug development programs is a growing requirement for many disease areas that have shifted from the one-drug-for-all to mechanism-matched clinical trial design. Like never before, biopharmaceutical companies are incorporating the use of biomarkers in diagnosing, monitoring and treating some of today’s most complex diseases.

Clinical research relies on diverse techniques, methodologies and matrices to test for markers key in identifying the right patient for the right drug, as well as demonstrating drug biological safety and efficacy. Learn more about how a comprehensive biomarker strategy can be crucial to ensuring clinical and commercial success of your product.

Related Services:
Best Practices for Integrating Biomarkers across the Drug Development Continuum

A roadmap for a successful biomarker strategy

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Read More